GlaxoSmithKline (Cyprus) Ltd
- R03 - Agentes contra padecimientos obstructivos de las vías respiratorias
- SERETIDE DISKUS inhalation powder, pre-dispensed 50 µg+100 µg
- SERETIDE DISKUS inhalation powder, pre-dispensed 50 µg+250 µg
- SERETIDE DISKUS inhalation powder, pre-dispensed 50 µg+500 µg
- SERETIDE EVOHALER pressurised inhalation, suspension 25 µg+50 µg